Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China flag China · Delayed Price · Currency is CNY
15.05
-0.04 (-0.27%)
Apr 21, 2026, 3:00 PM CST

SHA:688526 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
949.74933.041,027974.141,083
Other Revenue
-8.8837.1427.1219.86
949.74941.921,0641,0011,103
Revenue Growth (YoY)
0.83%-11.48%6.27%-9.22%30.81%
Cost of Revenue
313.67360.45321.43279.05230.42
Gross Profit
636.07581.48742.65722.22872.6
Selling, General & Admin
165.04169.4213.2219.26201.91
Research & Development
96.4186.1288.51102.7580
Other Operating Expenses
-13.61-0.93-0.826.295.92
Operating Expenses
247.84266.47385.36339.01296.9
Operating Income
388.23315.01357.29383.21575.71
Interest Expense
--4.77-8.16-5.45-1.81
Interest & Investment Income
7.4173.1794.1275.6971.86
Currency Exchange Gain (Loss)
-00.05--
Other Non Operating Income (Expenses)
65.27-0.72-0.21-0.2-0.27
EBT Excluding Unusual Items
460.91382.69443.1453.25645.48
Impairment of Goodwill
--3.31---
Gain (Loss) on Sale of Investments
33.2730.99-10.191.44-
Gain (Loss) on Sale of Assets
-0.93---
Asset Writedown
-12.64-0.53-1.72-0.14-1.57
Legal Settlements
----0.82
Other Unusual Items
-27.3626.3912.0615.32
Pretax Income
481.54438.13457.58466.61660.05
Income Tax Expense
64.656.646257.4689.41
Earnings From Continuing Operations
416.94381.49395.58409.15570.64
Minority Interest in Earnings
1.780.860.350.370.11
Net Income
418.72382.35395.93409.52570.74
Net Income to Common
418.72382.35395.93409.52570.74
Net Income Growth
9.51%-3.43%-3.32%-28.25%27.45%
Shares Outstanding (Basic)
465466466465464
Shares Outstanding (Diluted)
465466466465464
Shares Change (YoY)
-0.22%0.10%0.10%0.29%20.20%
EPS (Basic)
0.900.820.850.881.23
EPS (Diluted)
0.900.820.850.881.23
EPS Growth
9.76%-3.53%-3.41%-28.46%6.03%
Free Cash Flow
344.66285.74433.53320.86156.82
Free Cash Flow Per Share
0.740.610.930.690.34
Dividend Per Share
-0.4300.4300.1900.190
Dividend Growth
--126.32%--34.48%
Gross Margin
66.97%61.73%69.79%72.13%79.11%
Operating Margin
40.88%33.44%33.58%38.27%52.19%
Profit Margin
44.09%40.59%37.21%40.90%51.74%
Free Cash Flow Margin
36.29%30.34%40.74%32.05%14.22%
EBITDA
499.99423.23470.54480.16638.35
EBITDA Margin
52.64%44.93%44.22%47.95%57.87%
D&A For EBITDA
111.76108.22113.2496.9562.64
EBIT
388.23315.01357.29383.21575.71
EBIT Margin
40.88%33.44%33.58%38.27%52.19%
Effective Tax Rate
13.41%12.93%13.55%12.31%13.55%
Revenue as Reported
-941.921,0641,0011,103
Advertising Expenses
-25.734.12.872.96
Source: S&P Global Market Intelligence. Standard template. Financial Sources.